| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From Discoveries in Sight, Devers Eye Institute, Portland, Oregon.
PURPOSE. Glial cells are structurally and functionally linked to neuronal tissues. Pathologically, the cells may be activated and characterized by increased size and number and altered cellular properties. In glaucoma, pathologic mechanisms within the anterior optic nerve may include glial activation. This study examines morphologic changes of glial cells in the retinas of glaucomatous eyes compared with age-matched control retinas.
METHODS. Paraffin-processed or flatmounted retinas from 17 human donor eyes [7 normal (donor age, 87.3 ± 8.3 years) and 10 glaucomatous (donor age, 87.1 ± 6.9 years)] were examined. With immunohistochemical methods, retinal glial cells were stained with an antibody to glial fibrillary acidic protein (GFAP). The morphology of the glial cells in normal and glaucomatous retinas was evaluated with fluorescence microscopy.
RESULTS. Three types of glial cells were identified in flatmounted retinas with differing distributions in the peripapillary region, the nerve fiber layer (NFL), and along the capillaries. Compared with normal eyes, in glaucomatous retinas the glial cells in the peripapillary region showed an increase in density and exhibited a deformation of the end feet. The astrocytes distributed among the NFL showed little difference from normal. The astrocytes accompanying the capillary bed showed a redistribution in the glaucomatous retinas. The quantification of glial cells in paraffin-processed glaucomatous retinas exhibited a profound increase in density and a significant increase of GFAP immunoreactivity in contrast to the lightly stained glial cells in normal retinas.
CONCLUSIONS. The activation of glial cells in the glaucomatous retina was characterized in changes of intensity of GFAP immunoreactivity and morphology around the larger blood vessels, compared with age-matched normal retinas. The relationships between glial cells, neuronal cells, and the vasculature, as well as the potential role of glial cells in pathologic mechanisms during different stages of neuronal damage in glaucoma, are discussed.
This article has been cited by other articles:
|
|
 |
|
  G. Ho, S. Kumar, X. S. Min, Y. L. Kng, M. Y. Loh, S. Gao, and L. Zhuo Molecular Imaging of Retinal Gliosis in Transgenic Mice Induced by Kainic Acid Neurotoxicity Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2459 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tura, F. Schuettauf, P. P. Monnier, K. U. Bartz-Schmidt, and S. Henke-Fahle Efficacy of Rho-kinase Inhibition in Promoting Cell Survival and Reducing Reactive Gliosis in the Rodent Retina Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 452 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Harwerth, J. L. Wheat, and N. V. Rangaswamy Age-Related Losses of Retinal Ganglion Cells and Axons Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4437 - 4443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fortune, L. Wang, G. Cull, and G. A. Cioffi Intravitreal Colchicine Causes Decreased RNFL Birefringence without Altering RNFL Thickness Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 255 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saleh, M. Nagaraju, and V. Porciatti Longitudinal Evaluation of Retinal Ganglion Cell Function and IOP in the DBA/2J Mouse Model of Glaucoma Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4564 - 4572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Huang, J. B. Fileta, T. Filippopoulos, A. Ray, A. Dobberfuhl, and C. L. Grosskreutz Hsp27 Phosphorylation in Experimental Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4129 - 4135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakazawa, M. Takeda, G. P. Lewis, K.-S. Cho, J. Jiao, U. Wilhelmsson, S. K. Fisher, M. Pekny, D. F. Chen, and J. W. Miller Attenuated Glial Reactions and Photoreceptor Degeneration after Retinal Detachment in Mice Deficient in Glial Fibrillary Acidic Protein and Vimentin Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2760 - 2768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Harwerth, A. S. Vilupuru, N. V. Rangaswamy, and E. L. Smith III The Relationship between Nerve Fiber Layer and Perimetry Measurements Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 763 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Senatorov, I. Malyukova, R. Fariss, E. F. Wawrousek, S. Swaminathan, S. K. Sharan, and S. Tomarev Expression of Mutated Mouse Myocilin Induces Open-Angle Glaucoma in Transgenic Mice. J. Neurosci., November 15, 2006; 26(46): 11903 - 11914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ventura, N. Sorokac, R. D. L. Santos, W. J. Feuer, and V. Porciatti The Relationship between Retinal Ganglion Cell Function and Retinal Nerve Fiber Thickness in Early Glaucoma. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3904 - 3911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, B. Fortune, G. Cull, J. Dong, and G. A. Cioffi Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch Ophthalmol, May 1, 2006; 124(5): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Steele, D. M. Inman, D. J. Calkins, P. J. Horner, and M. L. Vetter Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 977 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Farkas, I. Chowers, A. S. Hackam, M. Kageyama, R. W. Nickells, D. C. Otteson, E. J. Duh, C. Wang, D. F. Valenta, T. L. Gunatilaka, et al. Increased Expression of Iron-Regulating Genes in Monkey and Human Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1410 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmed, K. M. Brown, D. A. Stephan, J. C. Morrison, E. C. Johnson, and S. I. Tomarev Microarray Analysis of Changes in mRNA Levels in the Rat Retina after Experimental Elevation of Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1247 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Maeda, A. Sawada, M. Matsubara, Y. Nakai, A. Hara, and T. Yamamoto A Novel Neuroprotectant against Retinal Ganglion Cell Damage in a Glaucoma Model and an Optic Nerve Crush Model in the Rat Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 851 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pavlidis, T. Stupp, R. Naskar, C. Cengiz, and S. Thanos Retinal Ganglion Cells Resistant to Advanced Glaucoma: A Postmortem Study of Human Retinas with the Carbocyanine Dye DiI Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5196 - 5205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tezel, B. C. Chauhan, R. P. LeBlanc, and M. B. Wax Immunohistochemical Assessment of the Glial Mitogen-Activated Protein Kinase Activation in Glaucoma Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3025 - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Lam, J. M. K. Kwong, and M. O. M. Tso Early Glial Responses after Acute Elevated Intraocular Pressure in Rats Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 638 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Naskar, M. Wissing, and S. Thanos Detection of Early Neuron Degeneration and Accompanying Microglial Responses in the Retina of a Rat Model of Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2962 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fortune, M. A. Bearse Jr, G. A. Cioffi, and C. A. Johnson Selective Loss of an Oscillatory Component from Temporal Retinal Multifocal ERG Responses in Glaucoma Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2638 - 2647. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
